Although subject to these constraints, FAERS offers real-world data on clinically relevant adverse events from drugs
Major trends in the forecast period include expansion of glp-1 therapies beyond diabetes, rising demand for long-acting and once-weekly formulations, growth of oral glp-1 receptor agonists, increasing focus on weight management indications, strategic partnerships and licensing agreements
Dunham has PCOS and her periods returned on semaglutide When Dunham started taking the drug she gradually started noticing changes over the first couple of months
The competitive landscape for oral GLP-1 therapy has narrowed considerably in orforglipron's favor
Metabolism The rapid absorption of melatonin allows it to reach its maximum plasma concentration after 40 min, with linear kinetics after oral administration at doses between 1-5 mg
A structured assessment framework helps providers systematize this decision-making and reduces the risk of preventable adverse events during treatment initiation
